Mr. Bergstrom's recent experience includes transactions in the following industries:

Technology

• Intuit, a provider of business and financial management solutions for small businesses, consumers, and accounting professionals, in numerous transactions, including its:
  • US$12 billion acquisition of Mailchimp
  • US$7.1 billion acquisition of Credit Karma
  • US$340 million acquisition of TSheets, Inc.
  • US$1.025 billion sale of Digital Insight, Intuit's Financial Services division, to Thoma Bravo
  • US$423 million acquisition of Demandforce and its subsequent sale to Internet Brands
  • US$360 million acquisition of Check
  • US$170 million acquisition of Mint Software
  • Sale of Quicken Business Unit to HIG Capital
  • Sale of Quickbase Business Unit to Welsh, Carson, Anderson & Stowe
• Avago Technologies Limited, a provider of analog semiconductors, custom chips, radio-frequency and microwave components, in numerous transactions, including its:
  • US$37 billion acquisition of Broadcom
  • US$6.6 billion acquisition of LSI Corporation
  • US$400 million acquisition of CyOptics
• Adobe Systems in its US$1.8 billion acquisition of Omniture

• Monsanto Company, an agricultural biotechnology company, in its US$930 million acquisition of the Climate Corporation
• OpenTable, a web-based service provider of restaurant reservations, in its US$2.6 billion sale to the Priceline Group    
• Twitch Interactive, an operator of a live video platform for online gaming, in its US$970 million sale to Amazon.com
• eBay in its US$945 million acquisition of Bill Me Later
• Seamless North America, a leading provider of mobile and online portals that provide restaurant information and services, in its merger with GrubHub 

Life Sciences

• Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company, in its acquisition by Merck
• MAP Pharmaceuticals, a drug and pharmaceutical company, in its US$958 million sale to Allergan
• Labrys Biologics, a biotechnology firm developing antibody treatments for chronic migraines, in its US$825 million sale to Teva Pharmaceutical Industries
• FerroKin BioSciences, a biotechnology company, in its US$325 million sale to Shire
• KAI Pharmaceuticals, a privately held pharmaceuticals company, in its US$315 million sale to  Amgen
• Complete Genomics, a developer of DNA sequencing products and services, in its US$117 million sale to BGI Shenzhen

Medical Devices

• Sorin S.p.A., a global medical device company, in its US$2.7 billion merger with Cyberonics
• LivaNova, a global medical device company, in the sale of its Cardiac Rhythm Management business to MicroPort
• Ulthera, a medical device company focused on the development and commercialization of various technologies for aesthetic and medical applications, in its:
  • US$600 million sale to Merz
  • Acquisition of Cabochon Aesthetics
• Sadra Medical, a company pioneering new therapies to minimize the invasiveness of treating aortic valve disease, in its US$450 million sale to Boston Scientific Corporation
• Maya Medical, a nascent hypertension product company, in its US$230 million sale to Covidien

Private Equity

Mr. Bergstrom’s private equity experience includes numerous transactions for private equity firms and sellers to private equity firms in both control and growth equity scenarios, including recent transactions such as:

• SRS Acquiom, in its sale of a majority interest to Lovell Minnick Partners
• PriceSpider, in its sale of a majority interest to Frontier Capital
• Canada Pension Plan Investment Board, in its acquisition of a 48% stake in GlobalLogic, a global leader in digital product development services
• Bridgepoint Advisers, in its acquisition with Summit Partners of Calypso Technology, a provider of financial market software solutions
• Data Device Corporation (DDC), a portfolio company of Behrman Capital, in its US$1 billion sale to TransDigm Group Incorporated